Maria Sandoval, MD, MS

Cancer Focus:
Anal Cancer, Brain Cancer, Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gallbladder Cancer, Liver (Hepatocellular) Cancer, Lung Cancer, Meningioma, Pancreatic Cancer, Prostate Cancer, Rectal Cancer

Dr. Maria Sandoval is an Assistant Member in the Department of Radiation Oncology at Moffitt Cancer Center. Dr. Sandoval received her MD degree from New York Medical College, Valhalla, New York. She completed a Radiation Oncology Residency at the University of South Florida, Morsani College of Medicine, Tampa. Dr. Sandoval’s clinical interest is in radiation oncology with a focus on gastrointestinal and thoracic malignancies. Her research interests are centered on advancing techniques that allow for personalized treatment, namely adaptive radiotherapy.

• Bryant JM, Sandoval M, Putney R, Trivedi P, Katende EN, Fink A, Naqvi SM, Kim Y, Yin V, Zhang J, Park JY, Serna A, Lam N, Pow-Sang J, Poch M, Li R, Manley BJ, Naghavi A, Torres-Roca J, Grass GD, Kim S, Latifi K, Hunt D, Johnstone P, Dhillon J, Rodriguez PC, Jain R, Fernandez DC, Yamoah K. Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer. J Immunother Cancer. 2026 May.14(5). Pubmedid: 42082271. Pmcid: PMC13141221.
• Singh P, Choo S, Adams J, Adams M, Lima Pereira AA, Baldonado JJA, Fontaine JP, Sandoval ML, Frakes JM, Pimiento JM, Hoffe SE, Sinnamon AJ. Is Site of Radiation Therapy Associated With Pathologic Complete Response in Patients With Locally Advanced Esophageal Cancer?. Cancer Control. 2025 Sep.32. Pubmedid: 40992780. Pmcid: PMC12461076.
• Nardella N, Adams M, Oraiqat A, Gonzalez BD, Thomas C, Goodchild S, Adamson S, Sandoval M, Frakes J, Palm RF, Stricker C, Herman J, Hodul P, Krüg S, Hoffe S. Personalizing Patient Education for Pancreatic Cancer Patients Receiving Multidisciplinary Care with Integration of Novel Digital Tools. Healthcare (Basel). 2025 Aug.13(15). Pubmedid: 40805962. Pmcid: PMC12345714.
• Bryant JM, Cruz-Chamorro RJ, Gan A, Liveringhouse C, Weygand J, Nguyen A, Keit E, Sandoval ML, Sim AJ, Perez BA, Dilling TJ, Redler G, Andreozzi J, Nardella L, Naghavi AO, Feygelman V, Latifi K, Rosenberg SA. Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesions. Commun Med (Lond). 2024 May.4(1):96. Pubmedid: 38778215. Pmcid: PMC11111790.
• Sandoval ML, Rishi A, Latifi K, Grass GD, Torres-Roca J, Rosenberg SA, Yamoah K, Johnstone PAS. Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy. Cancer Control. 2024 Jan.31. Pubmedid: 39206515. Pmcid: PMC11363040.
• Liveringhouse C, Netzley A, Bryant JM, Linkowski LC, Weygand J, Sandoval ML, Dohm A, Dookhoo M, Kelley S, Rosenberg SA, Latifi K, Torres-Roca JF, Johnstone PAS, Yamoah K, Grass GD. Trimodal Therapy Using an MR-guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder Cancer. Adv Radiat Oncol. 2023 May.8(6):101268. Pubmedid: 38047218. Pmcid: PMC10692296.
• Sandoval ML, Sim AJ, Bryant JM, Bhandari M, Wuthrick EJ, Perez BA, Dilling TJ, Redler G, Andreozzi J, Nardella L, Feygelman V, Latifi K, Rosenberg SA. Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions. JTO Clin Res Rep. 2023 May.4(5):100488. Pubmedid: 37159821. Pmcid: PMC10163640.
• Bryant JM, Weygand J, Keit E, Cruz-Chamorro R, Sandoval ML, Oraiqat IM, Andreozzi J, Redler G, Latifi K, Feygelman V, Rosenberg SA. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions. Cancers (Basel). 2023 Mar.15(7). Pubmedid: 37046741. Pmcid: PMC10093051.
• Dohm AE, Tang JD, Mills MN, Liveringhouse CL, Sandoval ML, Perez BA, Robinson TJ, Creelan BC, Gray JE, Etame AB, Vogelbaum MA, Forsyth P, Yu HM, Oliver DE, Ahmed KA. Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone. J Neurosurg. 2023 Jun.138(6):1600-1607. Pubmedid: 36681988.
• Webking S, Sandoval ML, Chuong MD, Ucar A, Aparo S, De Zarraga F, Sahin I, Biachi T, Kim DW, Hoffe SE, Frakes JM, Palm RF. Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma. Cancer Control. 2023 Jan.30. Pubmedid: 38038261. Pmcid: PMC10693219.
• Keit E, Liveringhouse C, Figura N, Weygand J, Sandoval ML, Garcia G, Peters J, Nieder M, Faramand R, Khimani F, Kim S, Robinson TJ, Johnstone PAS, Penagaricano J, Latifi K. Feasibility and Toxicity of Full-Body Volumetric Modulated Arc Therapy Technique for High-Dose Total Body Irradiation. Technol Cancer Res Treat. 2023 Jan.22. Pubmedid: 37287260. Pmcid: PMC10272663.
• Sandoval ML, Dohm A, Yamoah K. Management of early-stage metastatic prostate cancer: appraisal of locoregional treatments and radiation therapy, with or without immunomodulation. Endocr Relat Cancer. 2021 Jul.28(8):T109-T120. Pubmedid: 34061766.
• Sandoval ML, Youssef I, Latifi K, Grass GD, Torres-Roca J, Rosenberg S, Yamoah K, Johnstone PA. Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results. J Clin Med. 2021 Jul.10(15). Pubmedid: 34362179. Pmcid: PMC8347281.
• Sandoval ML, Rosen EB, Robert AJ, Nelson JA, Matros E, Gelblum DY. Immediate dental implants in fibula free flaps to reconstruct the mandible: A pilot study of the short-term effects on radiotherapy for patients with head and neck cancer. Clin Implant Dent Relat Res. 2020 Feb.22(1):91-95. Pubmedid: 31777154. Pmcid: PMC9348905.